Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a diabetes drug curb alcohol cravings? new trial investigates

NCT ID NCT06727331

First seen Nov 19, 2025 · Last updated May 20, 2026 · Updated 21 times

Summary

This small pilot study is testing whether tirzepatide, a drug used for diabetes, can help people with alcohol use disorder reduce their cravings for alcohol. Twenty adults will receive weekly injections of either tirzepatide or a placebo for 4 weeks. The goal is to see if the drug lowers cue-triggered cravings and is safe to use for this condition.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER (AUD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Brigham and Women's Faulkner Hospital

    RECRUITING

    Jamaica Plain, Massachusetts, 02130, United States

    Contact Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Brigham and Women's Hospital

    ACTIVE_NOT_RECRUITING

    Boston, Massachusetts, 02115, United States

Conditions

Explore the condition pages connected to this study.